Lite Strategy, Inc. — Director's Dealing 2023

Aug 2, 2023

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: MEI Pharma, Inc. (MEIP)
CIK: 0001262104
Period of Report: 2023-06-12

Reporting Person: File Justin J. (N/A)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$7.35	2033-06-12	Common Stock (53302)		Direct

Footnotes

F1: The option shall become exercisable with respect to 25% of the shares subject to the option on June 12, 2024, and the option shall become exercisable with respect to 2.0833% of the shares subject to the option on each of the next 36 calendar months following June 12, 2024.